<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03480607</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.05.85</org_study_id>
    <nct_id>NCT03480607</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine as Adjuvant for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block for Cleft Lip Repair</brief_title>
  <official_title>Comparative Evaluation of Dexamethasone and Dexmedetomidine as Adjuvants for Bupivacaine in Ultrasound Guided Infraorbital Nerve Block in Infants for Cleft Lip Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efﬁcacy of dexamethasone versus dexmedetomidine as adjuncts to bupivacaine for
      infra-orbital nerve block in infants undergoing cleft lip surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regarding patient registry; A prior G power analysis was done. Using the results obtained
      from previous studies and assuming an alpha error of 0.05 and beta error 0f 0.2 (power of the
      study 80 %), a sample size of 20 patients per group was calculated. A drop out 10% of cases
      is expected, so; 22 cases per group will be required.

      Statistical analysis: Data will be analyzed through SPSS (Statistical Package for Social
      Sciences). Program version 22. Distribution of data will be first tested by Shapiro test.
      Data will be presented as mean and standard deviation (SD), median and range or numbers and
      percentages. For normally distributed data, unpaired t test will be used to compare between
      mean values of both groups. For pain and sedation scores, Mann Whitney U test will be used.
      Fisher's exact test will be used for comparison of categorical data. The P value ≤ 0.05 will
      be considered as the level of statistical significance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">May 10, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative FLACC scale</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>FLACC scale: 0 : relaxed/ comfortable, 1-3 : mild discomfort, 4-6 : moderate discomfort, 7- 10: sever discomfort/ Pain / both,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative sedation score</measure>
    <time_frame>for 4 hours after surgery</time_frame>
    <description>The degree of sedation will be assessed by using a three point sedation scale based on eye opening: - Alert with spontaneous eye opening 0, - Drowsy with eyes only opening in response to speech 1, - Sedated with eyes opening in response to physical stimulation 2,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>For 4 hours after induction</time_frame>
    <description>(beat/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>For 4 hours after induction</time_frame>
    <description>(mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>As nausea can't be detected in this age group; so we will detect only if vomiting occur or not and number of attacks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematoma formation after surgery</measure>
    <time_frame>for 24 hours after surgery</time_frame>
    <description>That will be scored as follows; Yes: there is hematoma formation or No: no hematoma formation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative vomiting</measure>
    <time_frame>for 24 hours after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Cleft Lip</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexmedetomidine in conjunction with bupivacaine for infra-orbital nerve block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexamethasone in conjunction with bupivacaine f</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine group</intervention_name>
    <description>0.75 ml of 0.5% Bupivacaine in conjunction with 0.5 mcg/kg dexmedetomidine</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone group</intervention_name>
    <description>0.75 ml of 0.5% Bupivacaine in conjunction with 0.1 mcg/kg dexamethasone</description>
    <arm_group_label>Dexamethasone group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American society of anesthesiologist (ASA) physical status I or II

        Exclusion Criteria:

          -  known allergy to any of drugs used

          -  coagulopathy

          -  any wound or infection related to puncture site

          -  major illness

          -  failure to gain consent of parents.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enas Abd el Motlb, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mansoura University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enas A Abd el Motlb, MD</last_name>
    <phone>00201-005-401-236</phone>
    <email>sevo2006@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Said Emam, MD</last_name>
    <phone>+201008765995</phone>
    <email>sayedemam04@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mansoura University Childeren Hospital</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enas A Abd el Motlb, MD</last_name>
      <phone>00201-005-401-236</phone>
      <email>sevo2006@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Said Emam, MD</last_name>
      <phone>+201008765995</phone>
      <email>sayedemam04@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2018</study_first_submitted>
  <study_first_submitted_qc>March 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cleft Lip</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

